Skip to main content

Table 1 The Clinical and biochemical/ hormonal data in women with polycistic ovary syndrome (PCOS) patients and healthy controls

From: Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome

Variable Women with PCOS (n_40) Healthy controls (n_43) p
Age, years 22.97 ± 5.18 23.63 ± 4.60 >0.05
BMI, kg/m2 24.40 ± 5.82 25.44 ± 4.82 >0.05
Waist/hip ratio 0.84 ± 0.78 0.83 ± 0.73 >0.05
Fasting insulin, μ IU/ml 14.92 ± 9.96 9.25 ± 7.90 <0.01*
HOMA-IR 3.98(1.4-7.9) 1.91(0.74-4.84) <0.01*
Total cholesterol, mg/dl 179.63 ± 26.62 151.46 ± 26.74 <0.01*
Triglyceride, mg/dl 109.75 ± 54.92 78.82 ± 32.55 <0.01*
LDL-C, mg/dl 99.45 ± 26.60 84.72 ± 23.51 <0.01*
FSH, m IU/ml 5.39 ± 1.82 5.88 ± 1.76 >0.05
LH, m IU/ml 5.79 ± 1.94 5.76 ± 2.44 >0.05
Estradiol, pg/ml 43.44 ± 22.32 72.43 ± 38.00 <0.01*
Free testosterone,pg/m 2.81 ± 1.02 1.44 ± 0.62 <0.01*
17-OHprogesterone,ng/ml 1.41 ± 0.55 0.90 ± 0.64 <0.01*
DHEAS, μq/dl 275.65 ± 115.45 195.67 ± 92.75 <0.01*
CIMT, mm 0.51 ± 0.052 0.42 ± 0.043 <0.01*
Copeptin, pmol/L 12.61 ± 3.05 9.60 ± 2.80 <0.01*
  1. *p <0.05 was accepted as statistically significant.
  2. BMI body mass index, HOMA-IR homeostasis model assessment insulin resistance index, HDL-C high density lipoprotein cholesterol, LDL-C LOW density lipoprotein cholesterol, hs-CRP high-sensitive C- reactive protein, TSH thyroid stimulating hormone, FSH follicle-stimulating hormone, LH luteinizing hormone, DHEAS dehydroepiandrosterone sulfate, CIMT carotid intima media thickness.